Shock therapy for leg pain? tiny device may help PAD patients move more

NCT ID NCT03204825

Completed Symptom relief Sponsor: Glasgow Caledonian University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a small device called TENS, which sends mild electrical pulses to the skin, could reduce leg pain during walking in people with peripheral artery disease (PAD). It also looked at adding a patient education program to encourage more physical activity. The trial enrolled 95 participants and focused on whether a larger study is feasible, not on proving the treatment works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcutaneous Electrical Nerve Stimulation (TENS) device and patient education program
What this could lead to: If this works, it could offer a simple, non-drug way to reduce leg pain and help people with PAD become more active.
What could go wrong: This is a small feasibility study, not a large trial. It is designed to see if a bigger study is possible, not to prove the treatment works. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERMITTENT CLAUDICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia intermittent vascular claudication Motor Activity peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERMITTENT CLAUDICATION PERIPHERAL ARTERIAL DISEASE

Contacts and locations

Locations

Clinical Research Facility, Queen Elizabeth University Hospital

Glasgow, Strathcylde, G51 4TF, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.